ASH 2015 | How far are we from a cure for CLL?

Thomas Kipps

Thomas Kipps, MD from the University of California, San Diego, CA, discussed the current treatment landscape in chronic lymphocytic leukemia (CLL), considering the novel therapies being presented at the American Society of Hematology (ASH) 2015 Annual Meeting.

Share this video